⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Maternal Newborn Health Innovations (MNHI) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Maternal Newborn Health Innovations (MNHI)
↗Parsippany, NJ, USA
Maternal Newborn Health Innovations (MNHI) is a mission-driven Public Benefit Corporation (PBC) focused on reducing avoidable pain, harm, and mortality to mothers and newborns during childbirth. The company has developed OdonAssist™, a soft, inflatable, single-use medical device designed to assist vaginal births during prolonged or complicated second-stage labor.
MNHI operates with an international footprint, maintaining global headquarters in the United States, European headquarters in France, and a technology hub in Singapore. The company is venture-backed and committed to delivering high-impact, affordable healthcare innovations to underserved markets globally.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Obstetrics/Maternal Health
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$26M
Investors:AXA Investment Managers
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (OdonAssist™)
Modalities:Medical Device
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:AXA Investment Managers (Lead Investor)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Gary Cohen - CEO and Co-founder
LINKS
Website:mnhi.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Maternal Newborn Health Innovations (MNHI). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.